THIRUMALAI CHEMICALS LTD

103.7 -3.67 (-3.53%) Sell

TIRUMALCHM is a falling knife, continues to bleed every investor trying to catch it

13 min read

THIRUMALAI CHEMICALS LTD has destroyed investor wealth today. It delivered -3.53% to close at 103.7. It's recent 5 day performance has been +1.37%, -1.03%, -1.38%, +0.37% and +1.69%.

[Themes containing TIRUMALCHM]

TIRUMALCHM showed a bearish trend over the last 3 months. During this period TIRUMALCHM delivered -5.51% and saw a maximum drawdown of -21.79%. It has been unusually choppy during this period. Long term investors are better off avoiding investing in TIRUMALCHM till volatility reduces and a clear trend emerges.

Trend

TIRUMALCHM has been underperforming the NIFTY-50 index in recent time. It showed significant outperformance (compared to the NIFTY-50 index) from 2 Mar, 2016 to 9 Jan, 2018. Over the last 3 years and 1 month, TIRUMALCHM outperformed the NIFTY-50 index on 46% days. Which indicates that on days TIRUMALCHM outperforms the NIFTY-50 index, it's performance is marginally better than on the days it underperforms the NIFTY-50 index.

During the last three months TIRUMALCHM was mostly loss making and delivered on average -0.06% per day. It's best return during this period (of +6.58%) was on Wednesday, 19 Dec, 2018. While it's worst loss in the same period (of -3.98%) was on Monday, 12 Nov, 2018. The longest stort-term trends during this period were 5 profitable and losing days. The bullish trend (which returned +15.6%) started on 30 Oct, 2018 and went on till 5 Nov, 2018 while the bearish trend (which returned -9.86%) started on 14 Nov, 2018 and went on till 20 Nov, 2018.

The last 12 months saw TIRUMALCHM's investors making profits in 4 months and incurring losses in 8 months. TIRUMALCHM was less consistent in delivering monthly returs than NIFTY-50 index. TIRUMALCHM was also a more risky investment than NIFTY-50 index as it's worst month in the last year, May 2018, returned -26.92% compared to -6.42% returned by NIFTY-50 index in Sep 2018. TIRUMALCHM had a longer winning streak of losing months than NIFTY-50 index. It went down in 3 straight months (from May 2018 to Jul 2018) during which period it delivered -38.98%. It is interesting to note that both TIRUMALCHM and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

Stock market bubbles don't grow out of thin air. They have a solid basis in reality, but reality as distorted by a misconception.
-- George Soros

TIRUMALCHM is currently seeing overall fall in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in TIRUMALCHM's volatility from 24 Oct, 2018 to 21 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that TIRUMALCHM has significant negative skewness in it's return distribution. This indicates that TIRUMALCHM is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than TIRUMALCHM. Therefore, NIFTY-50 must receive a lower allocation than TIRUMALCHM in your portfolio. NIFTY-50 index usually has shorter drawdown period than TIRUMALCHM.

On a general note (since you are interested in TIRUMALCHM), three instruments that deserve special mention are BAJFINANCE, BRITANNIA and NIFTY-GS-15YRPLUS. They have all outperformed the market and must be closely watched for investment opportunities.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter